Alex Starr
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 7
- Pancreatic and Hepatic Oncology Research 3
-
- Curcumin's Biomedical Applications 5
- Co-authors
- Rami Ben‐Yosef (12 shared papers)Akiva M. Vexler (11 shared papers)Shahar Lev‐Ari (8 shared papers)Nadir Arber (6 shared papers)Joel Greif (3 shared papers)Dan Aderka (2 shared papers)Rami Khosravi (1 shared paper)Peter Altevogt (1 shared paper)
- Journals
- Targeted Oncology (2 papers)Oncogene (2 papers)The International Journal of Biological Markers (1 paper)Cancer Investigation (1 paper)The Prostate (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Alex Starr
18 papers receiving 852 citations
Peers
Comparison fields: 5 of 67
- Molecular Medicine 219
- Oncology 266
- Drug Discovery 2
- Biochemistry 29
- Pulmonary and Respiratory Medicine 86
Countries citing papers authored by Alex Starr
This map shows the geographic impact of Alex Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Starr more than expected).
Fields of papers citing papers by Alex Starr
This network shows the impact of papers produced by Alex Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Starr. The network helps show where Alex Starr may publish in the future.
Co-authors
The 25 scholars most cited alongside Alex Starr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 144 | |
| 2 | Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. | 2007 | 136 |
| 3 | 2007 | 126 | |
| 4 | 2007 | 105 | |
| 5 | 2005 | 68 | |
| 6 | 2006 | 53 | |
| 7 | 2009 | 52 | |
| 8 | 2010 | 52 | |
| 9 | 2014 | 42 | |
| 10 | 2011 | 29 | |
| 11 | 2011 | 16 | |
| 12 | 2012 | 15 | |
| 13 | 2007 | 13 | |
| 14 | 2005 | 8 | |
| 15 | 2011 | 6 | |
| 16 | 2007 | 3 | |
| 17 | 2007 | 2 | |
| 18 | 2006 | 1 |
About Alex Starr
Alex Starr is a scholar working on Oncology, Molecular Medicine, Pulmonary and Respiratory Medicine, Immunology and Immunology and Allergy, having authored 18 papers that have together received 871 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Curcumin's Biomedical Applications (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Prostate Cancer Treatment and Research (3 papers), Virus-based gene therapy research (2 papers), Lung Cancer Treatments and Mutations (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Molecular Medicine (219 citations), Oncology (266 citations), Drug Discovery (2 citations), Biochemistry (29 citations) and Pulmonary and Respiratory Medicine (86 citations). Alex Starr has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Rami Ben‐Yosef, Akiva M. Vexler, Shahar Lev‐Ari, Nadir Arber, Joel Greif, Dan Aderka, Rami Khosravi, Peter Altevogt, Eyal Sagiv and TIMOTHY Cragin WANG. Their work appears in journals such as Targeted Oncology, Oncogene, The International Journal of Biological Markers, Cancer Investigation and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.